“The therapy of idiopathic pulmonary fibrosis: what is next?” Vivien Somogyi, Nazia Chaudhuri, Sebastiano Emanuele Torrisi, et al. Eur Respir Rev 2019; 28: 190021.
Format: | Article |
---|---|
Language: | English |
Published: |
European Respiratory Society
2019-09-01
|
Series: | European Respiratory Review |
Online Access: | http://err.ersjournals.com/content/28/153/195021.full |
Similar Items
-
“Cellular mechanisms underlying steroid-resistant asthma.” Ridhima Wadhwa, Kamal Dua, Ian M. Adcock, Jay C. Horvat, Richard Y. Kim and Philip M. Hansbro. Eur Respir Rev 2019; 28: 190021.
Published: (2019-11-01) -
In search of the Somogyi effect
by: Evgenia Mikhaylovna Patrakeeva, et al.
Published: (2016-01-01) -
“Antifibrotic therapy for fibrotic lung disease beyond idiopathic pulmonary fibrosis.” Bridget F. Collins and Ganesh Raghu. Eur Respir Rev 2019; 28: 190022.
Published: (2019-11-01) -
“Intersections of lung progenitor cells, lung disease and lung cancer.” Carla F. Kim. Eur Respir Rev 2017; 26: 170054.
Published: (2017-10-01) -
On the Trace Anomaly of the Chaudhuri–Choi–Rabinovici Model
by: Nakayama Yu
Published: (2021-02-01)